Cargando…
Dendritic Cell Vaccines in Ovarian Cancer
Ovarian cancer (OC) is one of the most lethal malignant gynecologic tumors, characterized by an uncertain presentation and poor outcomes. With or without neoadjuvant chemotherapy, surgery followed by platinum-based chemotherapy and maintenance therapy are the basis for the treatment of ovarian cance...
Autores principales: | Zhang, Xi, He, Tianhui, Li, Yuan, Chen, Ling, Liu, Hongyu, Wu, Yu, Guo, Hongyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874064/ https://www.ncbi.nlm.nih.gov/pubmed/33584699 http://dx.doi.org/10.3389/fimmu.2020.613773 |
Ejemplares similares
-
Dendritic Cell Vaccination, Immune Regulation, and Clinical Outcomes in Ovarian Cancer
por: Goyne, Hannah E., et al.
Publicado: (2013) -
Development of a Dendritic Cell/Tumor Cell Fusion Cell Membrane Nano-Vaccine for the Treatment of Ovarian Cancer
por: Zhang, Lei, et al.
Publicado: (2022) -
Dendritic Cell-Targeted Vaccines
por: Cohn, Lillian, et al.
Publicado: (2014) -
Research progress of neoantigen-based dendritic cell vaccines in pancreatic cancer
por: Zhang, Xin, et al.
Publicado: (2023) -
Dendritic cell vaccine of gliomas: challenges from bench to bed
por: Zheng, Ye, et al.
Publicado: (2023)